MediKane exploits opportunities in diversified markets with Food-as-Medicine products

After spending nearly a decade laying the foundation for the internationalization of its Australian innovations, MediKane has seen its customer base expand to include a diverse set of market segments.

The Australia-based company addresses the need for herbal treatments, also known as Food-as-Medicine products, targeting several global chronic diseases. The company has a portfolio of natural, plant-based food products that are backed by scientific and clinical evidence that they improve health.

Historically, MediKane has focused on two markets, helping people manage blood sugar levels and acute constipation caused by opioid painkillers in medical offices.

The company now targets diversified market segments, covering medical, health, ingredients, animal health and white label.

Let’s walk through the market segments where MediKane offers or is ready to launch its line of reliable and innovative Food-as-Medicine products.

Health

Obesity, weight gain, lifestyle changes, and food choices have dramatically increased the number of people with high blood sugar (BSL). In Australia, a person develops diabetes every five minutes. There is no super potent medicine for this condition, and the focus is on managing lifestyle and diet choices.

In such a scenario, MediKane’s flagship product, NutriKane D, is well positioned to tap into the emerging BSL space. It has demonstrated a positive impact on elevated NBS in clinical trials.

As a food product, NutriKane D has received a green flag for claims from Food Standards Australia New Zealand (FSANZ) regarding the management of BSL.

MediKane’s primary markets for NutriKane D are the US, UK and Asia.

Learn more about all MediKane products

Medical

In the medical segment, the company mainly targets private and public hospitals. Opioid-induced constipation (OCI) is a common problem due to prolonged use of opioid medications, prescribed for pain management in patients after surgery.

However, OCI increases patient discomfort. It also increases the cumulative cost of treatment and hospital waiting times.

MediKane is actively pursuing NutriKane R’s main application areas with a focus on the Australian and US markets. In these countries, hospitals and private establishments are encouraged to optimize cost management by improving the availability of beds.

NutriKane R, already on the market, is designed for people who want to improve bowel health and regularity and are looking for natural medicines, as well as those in hospitals or senior care facilities with constipation.

Ingredients

MediKane also provides plant-based products to food processors through its division, MediKane Ingredients. Food processors use these ingredients to make finished products. Target segments include processed meat producers, health food manufacturers and bakeries.

MediKane suggests that this US$5.4 billion global market segment is expected to grow at a CAGR of 12.9% over the period 2020-2026.

MediKane has strong distribution networks in the ingredients market in Australia, Europe and the United States.

animal health

MediKane products from the NutriKane range work the same way in animals as they do in humans. In 2019, the global animal health market was worth US$637 million and growing at an annual rate of 6.4%, according to the company. The growth of the market is mainly supported by socio-economic factors and the humanization of pets.

MediKane has created a joint venture to exploit this segment. The company is called PetKane and several of the key staff involved have already performed scientific testing over the past five years on dogs, cats and horses, with NutriKane proving its effectiveness. PetKane develops relationships with a global network of veterinarians and other animal lovers.

PetKane now sells animal products in powder form under the Chica brand.

White mark

Due to the quality of the ingredients offered, MediKane has established a growing white label business. The company believes that its unique new product offerings have exceptional growth potential.

The company expects the human nutrition market to grow at a steady pace over the next few years due to growing consumer awareness of the benefits of healthy living and eating.

With a global presence and an innovative set of product offerings, MediKane is committed to becoming a leading provider of safe, plant-based Food-as-Medicine products for the treatment of acute and specific chronicles.